Catalyst

Slingshot members are tracking this event:

Top-line data from the first Phase 3 trial of AQX-1125 in in interstitial cystitis/bladder pain syndrome in Q3 2018

Source Link:
http://investor.aqxpharma.com/news-releases/news-release-details/aquinox-pharmaceuticals-announces-first-quarter-2018-financial

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
AQXP Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Additional Relevant Details Update on 05/08/2018: Initially expected in Q4 2017, the data is now due Q3 2018
http://investor.aqxp...
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Jun 27, 2018
Occurred Source:
http://investor.aqxpharma.com/news-releases/news-release-details/aquinox-announces-topline-results-phase-3-leadership-301
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Leadership 301, Aqx-1125, Interstitial Cystitis, Bladder Pain Syndrome
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.